Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 205 of the 222 references it cites were found in a registry or an index; 39 of the 219 sources its claims cite were checked for support.
Abstract
OBJECTIVE: This clinical practice guideline addresses the diagnosis and treatment of primary adrenal insufficiency. PARTICIPANTS: The Task Force included a chair, selected by The Clinical Guidelines Subcommittee of the Endocrine Society, eight additional clinicians experienced with the disease, a methodologist, and a medical writer. The co-sponsoring associations (European Society of Endocrinology and the American Association for Clinical Chemistry) had participating members. The Task Force received no corporate funding or remuneration in connection with this review. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to determine the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: The evidence used to formulate recommendations was derived from two commissioned systematic reviews as well as other published systematic reviews and studies identified by the Task Force. The guideline was reviewed and approved sequentially by the Endocrine Society's Clinical Guidelines Subcommittee and Clinical Affairs Core Committee, members responding to a web posting, and the Endocrine Society Council. At each stage, the Task Force incorporated changes in response to written comments. CONCLUSIONS: We recommend diagnostic tests for the exclusion of primary adrenal insufficiency in all patients with indicative clinical symptoms or signs. In particular, we suggest a low diagnostic (and therapeutic) threshold in acutely ill patients, as well as in patients with predisposing factors. This is also recommended for pregnant women with unexplained persistent nausea, fatigue, and hypotension. We recommend a short corticotropin test (250 μg) as the "gold standard" diagnostic tool to establish the diagnosis. If a short corticotropin test is not possible in the first instance, we recommend an initial screening procedure comprising the measurement of morning plasma ACTH and cortisol levels. Diagnosis of the underlying cause should include a validated assay of autoantibodies against 21-hydroxylase. In autoantibody-negative individuals, other causes should be sought. We recommend once-daily fludrocortisone (median, 0.1 mg) and hydrocortisone (15-25 mg/d) or cortisone acetate replacement (20-35 mg/d) applied in two to three daily doses in adults. In children, hydrocortisone (∼8 mg/m(2)/d) is recommended. Patients should be educated about stress dosing and equipped with a steroid card and glucocorticoid preparation for parenteral emergency administration. Follow-up should aim at monitoring appropriate dosing of corticosteroids and associated autoimmune diseases, particularly autoimmune thyroid disease.
Overview
CoChat Summary
TL;DR
This Endocrine Society clinical practice guideline provides evidence-based recommendations for diagnosing and treating primary adrenal insufficiency (PAI), emphasizing a low diagnostic threshold, the 250-µg short corticotropin test as the diagnostic gold standard, and glucocorticoid/mineralocorticoid replacement with adrenal crisis prevention. It also highlights major evidence gaps, including sparse randomized trial data for replacement regimens and limited diagnostic accuracy studies specifically in PAI.
Key findings
- For diagnosis, the guideline recommends testing patients with indicative symptoms/signs and using the standard-dose 250-µg corticotropin stimulation test as the “gold standard”; peak cortisol below 500 nmol/L (18 µg/dL) at 30 or 60 minutes indicates adrenal insufficiency. The high-dose ACTH stimulation test had a sensitivity of 92% (95% CI, 81–97%) for PAI based on five studies; no studies were available for the low-dose test in PAI. If corticotropin testing is not feasible, a morning cortisol <140 nmol/L (5 µg/dL) plus ACTH is suggested as a preliminary test.
- Autoimmune adrenalitis is the most common cause of PAI, accounting for up to 90% in Western countries; 21-hydroxylase autoantibodies should be measured, and about 30% of CYP21A2 autoantibody-positive individuals progressed to overt PAI during 5-year follow-up. In autoantibody-negative individuals, other causes should be sought, including adrenoleukodystrophy in males via very-long-chain fatty acids and adrenal CT for infiltrative or malignant disease.
- In adults, recommended replacement is hydrocortisone 15–25 mg/d or cortisone acetate 20–35 mg/d in two or three divided doses, with fludrocortisone starting at 50–100 µg/d (median, 0.1 mg) for confirmed aldosterone deficiency. Prednisolone 3–5 mg/d is an alternative, while dexamethasone is suggested against. DHEA replacement may be tried for 6 months in women with low libido, depressive symptoms, and/or low energy despite optimized replacement.
- For adrenal crisis, immediate parenteral hydrocortisone 100 mg (50 mg/m² for children) is recommended, followed by 200 mg/24 h (50–100 mg/m²/d for children), plus fluid resuscitation. Reported adrenal crisis frequencies were 6.6 crises/100 patient-years in a retrospective analysis of 444 patients and 8.3 crises/100 patient-years in a prospective study of 768 patient-years, with a crisis mortality rate of 0.5/100 patient-years.
Methods
- This is a GRADE-based clinical practice guideline developed by an Endocrine Society Task Force with a methodologist and medical writer; recommendations are graded strong (“we recommend,” 1) or weak (“we suggest,” 2), with evidence quality from QEEE (very low) to QQQQ (high), plus ungraded best practice statements.
- Evidence came from two commissioned systematic reviews and other published systematic reviews/studies. The first review compared high-dose vs low-dose ACTH stimulation for diagnosis and found only five studies for high-dose ACTH in PAI and none for low-dose ACTH in PAI. The second review compared glucocorticoid replacement regimens and identified 15 observational studies; mortality, bone density, and adrenal crisis data were very sparse or unavailable, and there was no statistically significant HRQoL difference between hydrocortisone dosages ≥30 mg/d vs <30 mg/d.
- The guideline was reviewed and approved sequentially by Endocrine Society committees, members responding to a web posting, and the Endocrine Society Council; the Task Force received no corporate funding or remuneration.
Limitations
- The paper states that the evidence base is limited: there are no randomized controlled trials for many treatment questions, diagnostic accuracy data for high-dose ACTH in PAI come from only five studies with none for low-dose ACTH in PAI, and the second systematic review found sparse or unavailable data on mortality, bone density, and adrenal crisis, with very low-quality evidence for extended-release/dual-release glucocorticoids. Many recommendations are weak or ungraded best practice statements.
- The paper states that cortisol cutoff values after corticotropin stimulation vary by assay, ACTH assays have analytical bias, and actual clinical cutpoints should be based on assay-specific normative data.
- Evident from the text: the guideline focuses only on PAI and explicitly excludes secondary adrenal insufficiency and critical illness-related corticosteroid insufficiency; some recommendations rely on clinical experience, unsystematic observations, and values/preferences rather than direct systematic evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Algorithm for the diagnostic approach to the patient with PAI. The most common causes of PAI are autoimmune destruction of the adrenal cortex in adults and CAH in children. These etiologies can be screened for using 21-hydroxylase antibodies and a baseline serum 17hydroxyprogesterone level. Males with negative 21-hydroxylase antibodies should be tested for adrenoleukodystrophy with plasma VLCFAs. If these diagnoses are excluded, a CT scan of the adrenals may reveal evidence of adrenal infiltrative processes or metastases. The individual's clinical picture and family history may render some steps in the algorithm redundant or suggest specific genetic syndromes. The latter includes subtypes of autoimmune polyglandular syndromes or specific rare genetic disorders where adrenal failure is part of a broader phenotype. A list of differential diagnoses is provided in Table 2. AHC, adrenal hypoplasia congenita; AI, adrenal insufficiency; VLCFA, very long chain fatty acid. a 17-OHprogesterone > 1000 ng/dL is diagnostic for 21-OH deficiency (14). b VLCFA should be measured in the initial evaluation of preadolescent boys. [Adapted from E. S. Husebye, et al: Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med . 2014;275:104-115 (181), with permission. © John Wiley & Sons, Inc.]](https://figures.cochat.ai/paper-figures/3d28d00e3ab049b5b513e655fd2f1f7a/diagnosis-and-treatment-of-primary-adrenal-insufficiency-an-endocrine-society-figure-1.png)
Verification
Claims the paper makes
35 Valid · 2 Not valid · 109 Not checked · 48 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“However, in all these reports, adrenal crisis was a significant cause of death.”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Disputedcites [149] 149. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addison's disease: a pop- ulation-based study. J Clin Endocrinol Metab. 2006;91:4849 - 4853. sourceExperimental — accuracy not yet measured
The Mortality section reports 36 deaths attributed to adrenal insufficiency but explicitly says that no patient was reported to have died from adrenal crisis under ICD-10. It also cautions that ICD-9 cannot distinguish adrenal crisis from primary adrenal insufficiency, so the study does not establish crisis as a significant cause of death. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [150] 150. Bensing S, Brandt L, Tabaroj F, et al. Increased death risk and altered cancer incidence pattern in patients with isolated or com- bined autoimmune primary adrenocortical insufficiency. Clin En- docrinol (Oxf). 2008;69:697-704. source
- Not checked — no full text of the sourcecites [7] 7. Erichsen MM, Løvås K, Fougner KJ, et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of prema- ture death. Eur J Endocrinol. 2009;160:233-237. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In addition to a paired sample of cortisol and ACTH, the adrenal reserve is appropriately and safely assessed in pregnancy by corticotropin stimulation, if indicated (40,41).”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Supportedcites [40] 40. Lebbe M, Arlt W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol (Oxf). 2013;78:497-502. source
The Investigations section (p. 3) calls the short Synacthen test a valid measure of adrenal cortisol reserve, including in pregnancy, and says there is no medical reason to avoid a single diagnostic dose in a pregnant woman. The Summary (p. 1) recommends the test when clinically feasible, alongside paired cortisol and ACTH measurements. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [41] 41. Suri D, Moran J, Hibbard JU, Kasza K, Weiss RE. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test. J Clin Endocrinol Metab. 2006;91:3866 -3872. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Patients with diseases such as nephrotic syndrome (43) and liver disease (50) as well as those who are in the immediate postoperative period (51) or who require intensive care (52) may have lower CBG and albumin and hence, lower cortisol measurements.”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Not checked — no full text of the sourcecites [43] 43. Klose M, Lange M, Rasmussen AK, et al. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocri- nol Metab. 2007;92:1326 -1333. source
- Not checked — no full text of the sourcecites [50] 50. Vincent RP, Etogo-Asse FE, Dew T, Bernal W, Alaghband-Zadeh J, le Roux CW. Serum total cortisol and free cortisol index give different information regarding the hypothalamus-pituitary-adre- nal axis reserve in patients with liver impairment. Ann Clin Biochem. 2009;46:505-507. source
- Supportedcites [51] 51. le Roux CW, Chapman GA, Kong WM, Dhillo WS, Jones J, Alagh- band-Zadeh J. Free cortisol index is better than serum total cortisol in determining hypothalamic-pituitary-adrenal status in patients undergoing surgery. J Clin Endocrinol Metab. 2003;88:2045- 2048. source
For the part attributed to this source—the immediate postoperative period—the Results report that albumin and CBG fell after surgery, and that seven patients had unexpectedly low postoperative total cortisol. The Discussion attributes those low cortisol values to the fall in CBG. The other conditions in the citing sentence have separate citations. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [52] 52. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004;350: 1629 -1638. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Interpretation of the diagnostic results requires thorough consideration of pregnancy-associated physiological changes of adrenocortical function (42).”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Supportedcites [42] 42. Jung C, Ho JT, Torpy DJ, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab. 2011;96:1533-1540. source
The Discussion (page not specified in the supplied passage) says that physiological hypercortisolism can be difficult to distinguish from Cushing’s syndrome during pregnancy and emphasizes trimester-specific reference ranges. This supports considering pregnancy-related adrenocortical changes when interpreting diagnostic results. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“An elevated ACTH concentration in the presence of a cortisol in the normal range can be the first sign of early-stage PAI (68).”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Could not verifycites [68] 68. Baker PR, Baschal EE, Fain PR, et al. Haplotype analysis discrim- inates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. J Clin Endo- crinol Metab. 2010;95:E263-E270. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that 21-hydroxylase autoantibodies usually precede overt Addison’s disease and proposes subsequent adrenal-function testing. Neither that passage nor the passages retrieved by searching for ACTH, cortisol, and early adrenal insufficiency addresses whether elevated ACTH with normal-range cortisol can be an early sign of PAI. (LLM, conf=0.73)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
118 more claims · 24 with their cited sources checked
Create a free account to see all 194 claims and every source verdict.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 58
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In children, glucocorticoid replacement therapy (GCCrt) should be started with hydrocortisone (HC) at a total daily dose of 10 mg/m2, with dose titration according to individual needs (35).”
From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“no drug suitably mimics the diurnal pattern of cortisol”
From Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells (2018) · cites this paper as Bornstein et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In such cases, a GC dosage increase of 20% to 40% from the 24th week onward is often beneficial (215).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [215]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, no consensus exists regarding the optimal dose and hydrocortisone delivery mode during major stress, and current recommendations are empirical rather than evidence-based (7, 17).”
From Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery (2020) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In primary and secondary adrenal insufficiency, peak cortisol levels < 500 nmol/L (< 18.1 μg/dL), depending on assay, are indicative of adrenal insufficiency (38, 39).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [38]
Experimental — accuracy not yet measured
25 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > 2.2
“We suggest the low-dose (1 g) corticotropin test for diagnosis of PAI only when the substance itself is in short supply.”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
“Thus, for practical reasons, the low-dose test may be applicable to situations when corticotropin is in short supply or for other structural or economic reasons.”
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group, an international group with expertise in development of evidence-based guidelines (15).”
MethodSapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Enhanced glucocorticoid secretion in critical illness is considered necessary to prevent defense mechanisms (eg, cytokine release) from overshooting with concomitant detrimental toxicity (142, 143).”
BackgroundSapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · cited 1×
“In newborns and children, mineralocorticoid sensitivity is lower, thereby usually requiring higher fludrocortisone doses compared to adults (106).”
BackgroundSpeiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 4×
“a 17-OHprogesterone 1000 ng/dL is diagnostic for 21-OH deficiency (14).”
BackgroundMethodInfluentialSelf-citationORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349 · cited 1×
“Serum DHEAS concentrations physiologically peak between ages 20 and 30 years, followed by a gradual decline that is independent of menopause (113).”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationCorticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Marik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912 · cited 1×
“Although similar arguments for the utility of the low-dose test have been proposed for other special diagnostic challenges such as the detection of adrenal insufficiency in critically ill patients (critical illness-related corticosteroid insufficiency), more evidence is needed to support such a formal recommendation (…”
BackgroundSelf-citationPharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886 · cited 1×
“Because of the short plasma half-life of hydrocortisone (approximately 90 min) (90), multiple dosing is recommended to mimic physiological conditions.”
BackgroundOelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737
Measurements of Serum Free Cortisol in Critically Ill Patients
Hamrahian, A. H., Oseni, T. S., & Arafah, B. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa020266 · Cited by 726 · cited 1×
“period (51) or who require intensive care (52) may have”
BackgroundDehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Self-citationCharmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490 · cited 1×
“Evidence Mortality of patients with PAI was increased in some (149, 150), but not all studies (7).”
BackgroundDaily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481
Reduced Cortisol Metabolism during Critical Illness
Boonen, E., Vervenne, H., Meersseman, P., Andrew, R., Mortier, L., Declercq, P. E., Vanwijngaerden, Y.-M., Spriet, I., Wouters, P. J., Vander Perre, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214969 · Cited by 477 · cited 1×
“Reduced cortisol metabolism has been shown during critical illness (146).”
BackgroundDiagnosis and management of adrenal insufficiency
Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70142-1 · Cited by 467 · cited 2×
“A hydrocortisone dose equivalent to that used for major surgical stress should be initiated at the onset of active labor (cervix dilation 4 cm and/or contractions every 5 min for the last hour) with a bolus injection of 100 mg hydrocortisone iv followed by continuous infusion of 200 mg hydrocortisone/24 hours (40, 122…”
BackgroundMethodSelf-citationHormonal Responses to Graded Surgical Stress
Chernow, B. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370070087013 · Cited by 459 · cited 1×
“Studies provide evidence for an endogenous increase in cortisol during anesthesia, surgery, trauma, and critical illness, with great interindividual variation (137–141).”
BackgroundDICKSTEIN, G., SHECHNER, C., NICHOLSON, W. E., ROSNER, I., SHEN-ORR, Z., ADAWI, F., & LAHAV, M. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-773 · Cited by 457 · cited 2×
“Traditionally, a peak cortisol concentration after acute stimulation with corticotropin exceeding 500 nmol/L (18 (cid:2) g/ dL) is accepted as evidence for sufficient adrenocortical responsiveness (32, 45–47).”
BackgroundAnti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
Meager, A., Visvalingam, K., Peterson, P., Möll, K., Murumägi, A., Krohn, K., Eskelin, P., Perheentupa, J., Husebye, E., Kadota, Y., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030289 · Cited by 453
Self-citationClinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442 · cited 1×
“Although it is more elaborate and requires endocrinological expertise, the corticotropin stimulation test is a superior diagnostic test with a higher degree of sensitivity and specificity than determination of morning cortisol and ACTH concentrations and is therefore preferred in all patients considered with the diffe…”
BackgroundOn the constitutional and local effects of disease of the supra-renal capsules
Addison, T. (1855) · Medical Entomology and Zoology · Cited by 437
21-hydroxylase, a major autoantigen in idiopathic Addison's disease
Winqvist, O., Karlsson, F. A., & Kämpe, O. (1992) · The Lancet · doi:10.1016/0140-6736(92)91829-w · Cited by 410
Husebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403 · cited 1×
“2014;275:104–115 (181), with permission.”
Self-citationHahner, S., Spinnler, C., Fassnacht, M., Burger-Stritt, S., Lang, K., Milovanovic, D., Beuschlein, F., Willenberg, H. S., Quinkler, M., & Allolio, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3191 · Cited by 394 · cited 1×
“In a first prospective study comprising 768 patient years, 8.3 crises/100 patient years were reported (128).”
BackgroundInfluentialSelf-citationA longitudinal study of plasma and urinary cortisol in pregnancy and postpartum
Jung, C., Ho, J. T., Torpy, D. J., Rogers, A., Doogue, M., Lewis, J. G., Czajko, R. J., & Inder, W. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2395 · Cited by 394 · cited 10×
“Importantly, the use of the estrogen-containing oral contraceptives will result in higher CBG with a corresponding rise in cortisol (43, 44).”
BackgroundInfluentialSelf-citationHunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7022 · Cited by 386
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis
Kazlauskaite, R., Evans, A. T., Villabona, C. V., Abdu, T. A. M., Ambrosi, B., Atkinson, A. B., Choi, C. H., Clayton, R. N., Courtney, C. H., Gonc, E. N., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0710 · Cited by 385 · cited 2×
“© John Wiley & Sons, Inc.] provides higher sensitivity in the diagnosis of secondary adrenal insufficiency than the high-dose test (18, 29).”
BackgroundDiagnosis of Adrenal Insufficiency
Dorin, R. I., Qualls, C. R., & Crapo, L. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00009 · Cited by 374
Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem
Salem, M., Tainsh, R. E., Bromberg, J., Loriaux, D. L., & Chernow, B. (1994) · Annals of Surgery · doi:10.1097/00000658-199404000-00013 · Cited by 357 · cited 3×
“Lower doses of hydrocortisone (25–75 mg/24 h) for surgical stress have been advocated in patients with secondary adrenal insufficiency (144, 145).”
BackgroundPredisposing Factors for Adrenal Insufficiency
Bornstein, S. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804635 · Cited by 356 · cited 2×
“A variety of rare conditions may require additional diagnostic measures like serological or microbiological testing (12, 83).”
BackgroundSelf-citationHahner, S., Loeffler, M., Bleicken, B., Drechsler, C., Milovanovic, D., Fassnacht, M., Ventz, M., Quinkler, M., & Allolio, B. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0884 · Cited by 346 · cited 3×
“Adrenal crisis due to insufficient glucocorticoid dose adjustment during pregnancy has been reported (120).”
BackgroundInfluentialSelf-citationJohannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329 · cited 4×
“Dual and slowrelease formulations of cortisol may better mimic circadian hormone release (104) but do not mimic the physiological pulsatile release of cortisol.”
BackgroundInfluentialFilipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321 · cited 1×
“Retrospective studies of patients taking higher doses of glucocorticoids in some cases, including prednisolone or dexamethasone, appear to show a tendency to adverse metabolic consequences including weight gain, dyslipidemia, and diabetes mellitus (102).”
BackgroundA rapid test of adrenocortical function
Wood, J. B., James, V. H. T., Frankland, A. W., & Landon, J. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91526-6 · Cited by 312 · cited 1×
“The corticotropin stimulation test is currently regarded as the diagnostic “gold standard” for the diagnosis of primary (but not secondary) adrenal insufficiency because it has been reasonably well studied and is validated against the insulin tolerance test for diagnostic accuracy (21–25).”
BackgroundSwiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302 · cited 1×
“A detailed description of the grading schemehasbeenpublishedelsewhere(16).”
Self-citationPW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Self-citationUDELSMAN, R., NORTON, J. A., JELENICH, S. E., GOLDSTEIN, D. S., LINEHAN, W. M., LORIAUX, D. L., & CHROUSOS, G. P. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-986 · Cited by 278
Transplantation of human islets without immunosuppression
Ludwig, B., Reichel, A., Steffen, A., Zimerman, B., Schally, A. V., Block, N. L., Colton, C. K., Ludwig, S., Kersting, S., Bonifacio, E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317561110 · Cited by 274 · cited 1×
“ment and encapsulation technologies (180).”
Self-citationAdrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.
Merke, D. P., Chrousos, G. P., Eisenhofer, G., Weise, M., Keil, M. F., Rogol, A. D., Van Wyk, J. J., & Bornstein, S. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431903 · Cited by 266 · cited 14×
“The most common causes of PAI are autoimmune destruction of the adrenal cortex in adults and CAH in children.”
BackgroundInfluentialSelf-citationAbdu, T. A. M., Elhadd, T. A., Neary, R. H., & Clayton, R. N. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5535 · Cited by 265
Subjective health status in Norwegian patients with Addison’s disease.
Løvås, K., Loge, J. H., & Husebye, E. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01466.x · Cited by 256 · cited 3×
“This includes symptoms of over- or under-substitution with glucocorticoids, reduced vitality and perception of general health, and reduced physical function, especially in women (3), which translates into reduced working capacity.”
BackgroundSelf-citationExtensive expertise in endocrinology: adrenal crisis
Allolio, B. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0824 · Cited by 251 · cited 2×
“Adrenal crisis in patients with known PAI is best prevented by patient education and increasing the glucocorticoid dosage in situations of stressors known to increase cortisol requirements (126).”
BackgroundSelf-citationALLOLIO, B., HOFFMANN, J., LINTON, E. A., WINKELMANN, W., KUSCHE, M., & SCHULTE, H. M. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00492.x · Cited by 244
Self-citationOelkers, W. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5939-1 · Cited by 243
Mah, P. M., Jenkins, R. C., Rostami‐Hodjegan, A., Newell‐Price, J., Doane, A., Ibbotson, V., Tucker, G. T., & Ross, R. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02106.x · Cited by 243 · cited 1×
“12 mg/kg) produced integrated cortisol levels over 6 hours reliably within the healthy control 95% confidence intervals, whereas fixed dosing at 10 mg hydrocortisone did not (95).”
BackgroundDelayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients
Bleicken, B., Ventz, M., Quinkler, M., & Hahner, S. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181db6b7a · Cited by 242 · cited 10×
“Conflicts of interest are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in sp…”
BackgroundInfluentialBensing, S., Brandt, L., Tabaroj, F., Sjöberg, O., Nilsson, B., Ekbom, A., Blomqvist, P., & Kämpe, O. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03340.x · Cited by 242 · cited 1×
“Evidence Mortality of patients with PAI was increased in some (149, 150), but not all studies (7).”
BackgroundErichsen, M. M., Løvås, K., Fougner, K. J., Svartberg, J., Hauge, E. R., Bollerslev, J., Berg, J. P., Mella, B., & Husebye, E. S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0550 · Cited by 240
Self-citationValue of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
HÄGG, E., ASPLUND, K., & LITHNER, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00780.x · Cited by 233 · cited 1×
“5 (cid:2) g/dL]) found in combination with an elevated concentration of ACTH indicates the inability of the adrenal cortex to respond to ACTH stimulation and is highly predictive for PAI (19, 20, 66, 67).”
BackgroundKerrigan, J. R., Veldhuis, J. D., Leyo, S. A., Iranmanesh, A., & Rogol, A. D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501158 · Cited by 228
Zelissen, P. M. J., Croughs, R. J. M., van Rijk, P. P., & Raymakers, J. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00005 · Cited by 225 · cited 1×
“There is some evidence that aldosterone increases during normal pregnancy (41) and serum progesterone steadily increases throughout pregnancy, exerting some anti-mineralocorticoid effect; hence, fludrocortisone dose adjustments are sometimes required (121).”
BackgroundPlat, L., Leproult, R., L’Hermite-Baleriaux, M., Fery, F., Mockel, J., Polonsky, K. S., & Van Cauter, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5978 · Cited by 225 · cited 1×
“mimic the circadian rhythm and also to avoid high doses in the evening, which may compromise sleep and insulin sensitivity (91, 92).”
BackgroundIs the Prevalence of Addison's Disease Underestimated?
Laureti, S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1762 · Cited by 212
Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205 · cited 1×
“Using the fluctuating normal range of cortisol throughout the 24-hour day as a goal, Peacey et al (93) and Howlett (94) independently recommended 10 mg hydrocortisone on awakening, 5 mg at lunchtime, and 5 mg in the early evening.”
MethodEvaluation of the Integrity of the Hypothalamic-Pituitary-Adrenal Axis by Insulin Hypoglycemia Test1
Erturk, E., Jaffe, C. A., & Barkan, A. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4980 · Cited by 204 · cited 1×
“Itshouldbenotedthatthechoiceofwhatmorningcortisol concentration to utilize to rule out adrenal insufficiency (100% sensitivity) is controversial, with studies arguing lev-elsfrom (cid:4) 285nmol/L(10.3 (cid:2) g/dL)(23)to (cid:4) 480nmol/L(17 (cid:2) g/dL) (62).”
BackgroundInfluentialCortisol production rate in childhood and adolescence
Linder, B. L., Esteban, N. V., Yergey, A. L., Winterer, J. C., Loriaux, D. L., & Cassorla, F. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80128-3 · Cited by 202 · cited 1×
“Estimates of normal cortisol secretion rate can be used to determine an initial hydrocortisone dose (85).”
MethodWinqvist, O., Gustafsson, J., Rorsman, F., Karlsson, F. A., & Kämpe, O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116843 · Cited by 201 · cited 1×
“Additional testing can include measurement of CYP11A1 autoantibodies (160), the presence of which is correlated to premature ovarian insufficiency, although the protein is expressed in all steroidogenic tissues.”
BackgroundGuideline panels should not GRADE good practice statements
Guyatt, G. H., Schünemann, H. J., Djulbegovic, B., & Akl, E. A. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.011 · Cited by 201 · cited 1×
“The intention of these statements is to draw attention and remind providers of these principles, and these statements should not be considered as graded recommendations (17).”
BackgroundPurnell, J. Q., Brandon, D. D., Isabelle, L. M., Loriaux, D. L., & Samuels, M. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030440 · Cited by 199
Knutsson, U., Dahlgren, J., Marcus, C., Rosberg, S., Brönnegård, M., Stierna, P., & Albertsson-Wikland, K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3769 · Cited by 198
Oelkers, W., Diederich, S., & Bähr, V (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1320051 · Cited by 193 · cited 3×
“Furthermore, plasma renin activity in the upper reference range has been found to be a useful marker for a correct mineralocorticoid dose (38, 107, 108).”
BackgroundAssociated Autoimmunity in Addison's Disease
Zelissen, P. M. J., Bast, E. J. E. G., & Croughs, R. J. M. (1995) · Journal of Autoimmunity · doi:10.1006/jaut.1995.0009 · Cited by 190
Studies of the control of plasma aldosterone concentration in normal man
Williams, G. H., Cain, J. P., Dluhy, R. G., & Underwood, R. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106974 · Cited by 188 · cited 1×
“Fludrocortisone is routinely taken once daily in the morning, the rationale being that aldosterone level is highest at this time because it follows a circadian rhythm similar to cortisol (105).”
BackgroundThe Diagnosis and Management of Central Hypoadrenalism
Grossman, A. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0982 · Cited by 187
Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
Raff, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1166 · Cited by 186 · cited 1×
“There are some limitations from the collection and analysis perspective, but these can be dealt with (165).”
BackgroundLINDHOLM, J., & KEHLET, H. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb03638.x · Cited by 178 · cited 1×
“Cosyntropin-stimulated cortisol levels are slightly higher at 60 vs 30 minutes; however, the 30-minute time point has been validated against the insulin tolerance test (56).”
BackgroundPlat, L. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3082 · Cited by 177
Rapid adrenocorticotropic hormone test in practice. Retrospective review
May, M. E., & Carey, R. M. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90517-0 · Cited by 174 · cited 1×
“Traditionally, a peak cortisol concentration after acute stimulation with corticotropin exceeding 500 nmol/L (18 (cid:2) g/ dL) is accepted as evidence for sufficient adrenocortical responsiveness (32, 45–47).”
BackgroundAn assessment of optimal hydrocortisone replacement therapy
Howlett, T. A. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1340955.x · Cited by 169 · cited 1×
“Using the fluctuating normal range of cortisol throughout the 24-hour day as a goal, Peacey et al (93) and Howlett (94) independently recommended 10 mg hydrocortisone on awakening, 5 mg at lunchtime, and 5 mg in the early evening.”
MethodMallappa, A., Sinaii, N., Kumar, P., Whitaker, M. J., Daley, L.-A., Digweed, D., Eckland, D. J. A., Van Ryzin, C., Nieman, L. K., Arlt, W., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3809 · Cited by 167
Self-citationAdrenal crisis in treated Addison's disease: a predictable but under-managed event
White, K., & Arlt, W. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0559 · Cited by 160 · cited 2×
“Only 12% of patients with an adrenal crisis in the previous year gave themselves an injection; over two-thirds relied on medical personnel for their first line of treatment (127).”
BackgroundSelf-citationJones, S. L., Trainer, P. J., Perry, L., Wass, J. A. H., Besser, G. M., & Grossman, A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03793.x · Cited by 159
El‐Farhan, N., Pickett, A., Ducroq, D., Bailey, C., Mitchem, K., Morgan, N., Armston, A., Jones, L., Evans, C., & Rees, D. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12039 · Cited by 158 · cited 3×
“Importantly, the use of the estrogen-containing oral contraceptives will result in higher CBG with a corresponding rise in cortisol (43, 44).”
BackgroundInfluentialThe natural history of adrenal function in autoimmune patients with adrenal autoantibodies
Betterle, C., Scalici, C., Presotto, F., Pedini, B., Moro, L., Rigon, F., & Mantero, F. (1988) · Journal of Endocrinology · doi:10.1677/joe.0.1170467 · Cited by 155 · cited 1×
“Thus, an elevated plasma renin activity or concentration in combination with an (inap-propriately) normal or low serum aldosterone concentration is suggestive of PAI (38, 71–74).”
BackgroundContinuous subcutaneous hydrocortisone infusion in Addison’s disease
Løvås, K., & Husebye, E. S. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0052 · Cited by 155 · cited 1×
“Cortisol replacement by means of continuous sc infusion using insulin pumps provides a similar circadian rhythm, also mimicking the early morning increase in cortisol (172, 173).”
BackgroundSelf-citationChortis, V., Taylor, A. E., Schneider, P., Tomlinson, J. W., Hughes, B. A., O'Neil, D. M., Libé, R., Allolio, B., Bertagna, X., Bertherat, J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2851 · Cited by 154
Self-citationNovel liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for measuring steroids
Keevil, B. G. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.015 · Cited by 154 · cited 1×
“Another ma-joradvantageofLC-MS/MSoverimmunoassaysisitsability to quantify in a single analysis multiple steroids, in some methods up to 15 or more, thereby substantially broadening identification of different forms and underlying causes of adrenal insufficiency (166).”
Schmidt, I. L., Lahner, H., Mann, K., & Petersenn, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021897 · Cited by 149 · cited 2×
“Itshouldbenotedthatthechoiceofwhatmorningcortisol concentration to utilize to rule out adrenal insufficiency (100% sensitivity) is controversial, with studies arguing lev-elsfrom (cid:4) 285nmol/L(10.3 (cid:2) g/dL)(23)to (cid:4) 480nmol/L(17 (cid:2) g/dL) (62).”
BackgroundInfluentialA double-blind study of perioperative steroid requirements in secondary adrenal insufficiency
Glowniak, J. V., & Loriaux, D. L. (1997) · Surgery · doi:10.1016/s0039-6060(97)90280-4 · Cited by 148 · cited 1×
“Lower doses of hydrocortisone (25–75 mg/24 h) for surgical stress have been advocated in patients with secondary adrenal insufficiency (144, 145).”
BackgroundAlkatib, A. A., Cosma, M., Elamin, M. B., Erickson, D., Swiglo, B. A., Erwin, P. J., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0672 · Cited by 147 · cited 1×
“A systematic review and metaanalysis of randomized placebo controls of DHEA treatment have not shown any substantial clinical benefit, suggesting that the current evidence is insufficient to support routine use of DHEA in women with adrenal insufficiency (117).”
Backgroundle Roux, C. W., Chapman, G. A., Kong, W. M., Dhillo, W. S., Jones, J., & Alaghband-Zadeh, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021532 · Cited by 146
Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease
Mayenknecht, J., Diederich, S., Bähr, V., Plöckinger, U., & Oelkers, W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4831 · Cited by 142
Klose, M., Lange, M., Rasmussen, A. K., Skakkebæk, N. E., Hilsted, L., Haug, E., Andersen, M., & Feldt-Rasmussen, U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1791 · Cited by 140 · cited 1×
“such as nephrotic syndrome (43) and liver disease (50)”
BackgroundKnutsson, U. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.536 · Cited by 140
Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency
Reisch, N., Willige, M., Kohn, D., Schwarz, H.-P., Allolio, B., Reincke, M., Quinkler, M., Hahner, S., & Beuschlein, F. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0161 · Cited by 136 · cited 1×
“9 adrenal crises/100 patient years after correction for a neonatal salt-wasting crisis) (129).”
BackgroundSelf-citationBonfig, W., Dalla Pozza, S. B., Schmidt, H., Pagel, P., Knorr, D., & Schwarz, H. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0942 · Cited by 136 · cited 1×
“In patients with CAH, glucocorticoid dosages exceeding 20 mg/m(2)/d in infants and 15 to 17 mg/m(2)/d in adolescents have been shown to result in loss of height and shorter adult stature (124, 125).”
BackgroundØksnes, M., Björnsdottir, S., Isaksson, M., Methlie, P., Carlsen, S., Nilsen, R. M., Broman, J.-E., Triebner, K., Kämpe, O., Hulting, A.-L., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4253 · Cited by 134
Self-citationLaureti, S., Bellis, A. D., Muccitelli, V. I., Calcinaro, F., Bizzarro, A., Rossi, R., Bellastella, A., Santeusanio, F., & Falorni, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5149 · Cited by 129
Use of ACTH in the diagnosis of adrenal cortical insufficiency
Jenkins, D., Forsham, P. H., Laidlaw, J. C., Reddy, W. J., & Thorn, G. W. (1955) · The American Journal of Medicine · doi:10.1016/0002-9343(55)90200-x · Cited by 127 · cited 1×
“lation and is highly predictive for PAI (19, 20, 66, 67).”
BackgroundCoco, G., Dal Pra, C., Presotto, F., Albergoni, M. P., Canova, C., Pedini, B., Zanchetta, R., Chen, S., Furmaniak, J., Rees Smith, B., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0860 · Cited by 127 · cited 1×
“Following CYP21A2 autoantibody-positive individuals revealed that about 30% progressed to overt PAI during a 5-year follow-up (72).”
BackgroundReato, G., Morlin, L., Chen, S., Furmaniak, J., Smith, B. R., Masiero, S., Albergoni, M. P., Cervato, S., Zanchetta, R., & Betterle, C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0414 · Cited by 118 · cited 2×
“Using the less sensitive immunofluorescence assay of steroid-cell autoantibodies, Reato et al (159) found that three of 13 seropositive patients developed premature ovarian insufficiency during a mean observation period of 8 years, indicating that the predictive value is not that high.”
MethodClinical clues to the cause of Addison's disease
Vita, J. A., Silverberg, S. J., Goland, R., Austin, J. H. M., & Knowlton, A. I. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90339-0 · Cited by 113 · cited 1×
“A variety of rare conditions may require additional diagnostic measures like serological or microbiological testing (12, 83).”
BackgroundTorpy, D. J., Bachmann, A. W., Grice, J. E., Fitzgerald, S. P., Phillips, P. J. J., Whitworth, J. A., & Jackson, R. V. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7724 · Cited by 112
Self-citationForss, M., Batcheller, G., Skrtic, S., & Johannsson, G. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-8 · Cited by 109 · cited 1×
“However, outcome studies confirming this hypothesis are lacking, and less-frequent dosing may be associated with better compliance (100).”
BackgroundRemission of subclinical adrenocortical failure in subjects with adrenal autoantibodies.
De Bellis, A., Bizzarro, A., Rossi, R., Paglionico, V. A., Criscuolo, T., Lombardi, G., & Bellastella, A. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.4.8473373 · Cited by 106
Laureti, S., Casucci, G., Santeusanio, F., Angeletti, G., Aubourg, P., & Brunetti, P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636252 · Cited by 101 · cited 1×
“Young males and males without autoantibodies should be screened for adrenoleukodystrophy by measuring very-long chain fatty acids (81, 82).”
BackgroundIncreasing prevalence of Addison's disease in German females: health insurance data 2008–2012
Meyer, G., Neumann, K., Badenhoop, K. W. J., & Linder, R. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0756 · Cited by 98
Newell-Price, J. D. C., Whiteman, M. C., Rostami‐Hodjegan, A., Darzy, K. H., Shalet, S. M., Tucker, G. T., & Ross, R. J. M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03011.x · Cited by 92 · cited 1×
“Other modified and delayed-release formulations of hydrocortisone in clinical development aim to mimic the cortisol circadian rhythm (170, 171).”
BackgroundDhillo, W. S., Kong, W., le Roux, C. W., Alaghband-Zadeh, J., Jones, J., Carter, G., Mendoza, N., Meeran, K. M., & O'Shea, D. B. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460231 · Cited by 91 · cited 9×
“Importantly, the use of the estrogen-containing oral contraceptives will result in higher CBG with a corresponding rise in cortisol (43, 44).”
BackgroundInfluentialAddison's disease: a survey on 633 patients in Padova
Betterle, C., Scarpa, R., Garelli, S., Morlin, L., Lazzarotto, F., Presotto, F., Coco, G., Masiero, S., Parolo, A., Albergoni, M. P., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0528 · Cited by 90 · cited 1×
“Type 1 diabetes is present in 10–15% of patients in Scandinavia (7), but is less frequent in other populations (156–158).”
BackgroundLaboratory challenges in primary aldosteronism screening and diagnosis
Rehan, M., Raizman, J. E., Cavalier, E., Don-Wauchope, A. C., & Holmes, D. T. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.01.003 · Cited by 89
Self-citationWhat Affects the Quality of Life in Autoimmune Addison's Disease?
Meyer, G., Hackemann, A., Penna-Martinez, M., & Badenhoop, K. (2013) · Hormone and Metabolic Research · doi:10.1055/s-0032-1331766 · Cited by 88 · cited 1×
“Moreover, long-term HRQoL in these patients appears to be inversely re-lated to the delay in establishing the diagnosis after disease onset, emphasizing the importance of recognizing the disease early (5, 6).”
BackgroundTajima, T., Okada, T., Ma, X.-M., Ramsey, W. J., Bornstein, S. R., & Aguilera, G. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301018 · Cited by 88
Self-citationCorticosteroid-binding globulin: The clinical significance of altered levels and heritable mutations
Gagliardi, L., Ho, J. T., & Torpy, D. J. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.015 · Cited by 88 · cited 1×
“Plasma cortisol is 80% bound to CBG and 10–15% to albumin, so disorders that reduce (inflammation, rare genetic disorders) or increase CBG levels (estrogen, pregnancy, mitotane) need to be considered in interpretation of plasma cortisol levels (36).”
BackgroundSelf-citationLaureti, S., Aubourg, P. R., Calcinaro, F., Rocchiccioli, F., Casucci, G., Angeletti, G., Brunetti, P., Lernmark, Å., Santeusanio, F., & Falorni, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5103 · Cited by 87 · cited 1×
“…the vast majority of adult cases, and screening for specific auto-antibodies against CYP21A2 and for other associated autoimmune diseases is important, keeping in mind that the laboratory tests for the autoantibodies are not standardized and are subject to wide between-method variation (7, 76–79).”
BackgroundLebbe, M., & Arlt, W. (2013) · Clinical Endocrinology · doi:10.1111/cen.12097 · Cited by 86 · cited 5×
“In addition to a paired sample of cortisol and ACTH, the adrenal reserve is appropriately and safely assessed in pregnancy by corticotropin stimulation, if indicated (40, 41).”
BackgroundMethodInfluentialSelf-citationGagliardi, L., Nenke, M. A., Thynne, T. R. J., von der Borch, J., Rankin, W. A., Henley, D. E., Sorbello, J., Inder, W. J., & Torpy, D. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2433 · Cited by 85 · cited 1×
“In a smaller double-blind study, no impact on HRQoL was seen (174).”
BackgroundSelf-citationCharmandari, E., Kino, T., & Chrousos, G. P. (2013) · Endocrine development · doi:10.1159/000342505 · Cited by 85
Giordano, R., Marzotti, S., Balbo, M., Romagnoli, S., Marinazzo, E., Berardelli, R., Migliaretti, G., Benso, A., Falorni, A., Ghigo, E., et al. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345773 · Cited by 84 · cited 1×
“There are also a number metabolic or cardiovascular complications including hypertension (167).”
BackgroundCorticosteroid Insufficiency in Acutely Ill Patients
Annane, D., Briegel, J., & Sprung, C. L. (2003) · New England Journal of Medicine · doi:10.1056/nejm200305223482123 · Cited by 83
OELKERS, W., BOELKE, T., BÄHR, V., EXNER, P., FAUST, B., & HARENDT, H. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-181 · Cited by 81 · cited 3×
“upper limit of the reference interval (19, 20).”
BackgroundSubcutaneous hydrocortisone administration for emergency use in adrenal insufficiency
Hahner, S., Burger-Stritt, S., & Allolio, B. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1057 · Cited by 81 · cited 1×
“In a single-center, open-label, randomized, crossover study of 12 patients with PAI, sc and im injection of hydrocortisone had similar pharmacokinetics; however, sc injection required two single injections (vs one im injection) and had slower time to reach a cortisol level 1000 nmol/L ( 36 g/dL) (22 vs 11 min) (147).”
BackgroundSelf-citationAssessment of ACTH assay variability: a multicenter study
Pecori Giraldi, F., Saccani, A., Cavagnini, F., & _, _. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0962 · Cited by 80 · cited 1×
“lytical bias demonstrated in ACTH assays (69, 70).”
BackgroundRepping-Wuts, H. J. W. J., Stikkelbroeck, N. M. M. L., Noordzij, A., Kerstens, M., & Hermus, A. R. M. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1094 · Cited by 80 · cited 1×
“Thus, patient education for prevention of adrenal crisis and the use of emergency glucocorticoids is greatly needed (151).”
BackgroundSuri, D., Moran, J., Hibbard, J. U., Kasza, K., & Weiss, R. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1049 · Cited by 80 · cited 3×
“In addition to a paired sample of cortisol and ACTH, the adrenal reserve is appropriately and safely assessed in pregnancy by corticotropin stimulation, if indicated (40, 41).”
BackgroundIs a 0900-h serum cortisol useful prior to a short Synacthen test in outpatient assessment?
le Roux, C., Meeran, K., & Alaghband-Zadeh, J. (2002) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/0004563021901919 · Cited by 77 · cited 1×
“Unfortunately, most of the primary reports detailing this cutoff value are not based on subjects with PAI (23, 24, 61–64).”
BackgroundRapid Assessment of Corticotropin Reserve After Pituitary Surgery
Watts, N. B. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720050044021 · Cited by 76 · cited 1×
“Unfortunately, most of the primary reports detailing this cutoff value are not based on subjects with PAI (23, 24, 61–64).”
BackgroundWeise, M., Drinkard, B., Mehlinger, S. L., Holzer, S. M., Eisenhofer, G., Charmandari, E., Chrousos, G. P., & Merke, D. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032051 · Cited by 75 · cited 1×
“High-intensity exercise for 20 minutes did not require additional hydrocortisone in CAH patients (135).”
BackgroundSelf-citationDehydroepiandrosterone Replacement in Women With Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M. E., Schulte, H. M., et al. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200003000-00022 · Cited by 73 · cited 1×
“DHEA replacement in PAI with a single oral dose has been shown to restore circulating levels of androgen precursors and androgens back to the normal range (3, 114).”
BackgroundSelf-citationThe diagnosis and investigation of adrenal insufficiency in adults
Wallace, I., Cunningham, S., & Lindsay, J. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009101 · Cited by 73
Addison Disease in Adults: Diagnosis and Management
Chakera, A. J., & Vaidya, B. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.017 · Cited by 72
Plasma catecholamines in patients with Addison's disease
Bornstein, S. R., Breldert, M., Ehrhart‐Bornstein, M., Kloos, B., & Scherbaum, W. A. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01866.x · Cited by 70 · cited 1×
“There is an impairment of adrenomedullary function including the regulation of catecholamines and neuropeptides (168).”
BackgroundSelf-citationAutoantibody diagnostics in clinical practice
Conrad, K., Roggenbuck, D., Reinhold, D., & Sack, U. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.014 · Cited by 64 · cited 1×
“…the vast majority of adult cases, and screening for specific auto-antibodies against CYP21A2 and for other associated autoimmune diseases is important, keeping in mind that the laboratory tests for the autoantibodies are not standardized and are subject to wide between-method variation (7, 76–79).”
BackgroundMagnotti, M., & Shimshi, M. (2008) · Endocrine Practice · doi:10.4158/ep.14.2.233 · Cited by 62
Therapeutic management of adrenal insufficiency
Hahner, S., & Allolio, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.009 · Cited by 61 · cited 1×
“placement therapy is often reduced (3, 4).”
Self-citationSimon, N., Castinetti, F., Ouliac, F., Lesavre, N., Brue, T., & Oliver, C. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531290-000000000-00000 · Cited by 61 · cited 1×
“mimic the circadian rhythm and also to avoid high doses in the evening, which may compromise sleep and insulin sensitivity (91, 92).”
BackgroundCharmandari, E., & Kino, T. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02336.x · Cited by 60 · cited 1×
“However, caution is required because adrenocortical function test re-sults may be severely affected by rare conditions such as cortisol-binding globulin (CBG) deficiency, glucocorticoid resistance, and hypersensitivity (33–36).”
BackgroundHIGHLY POTENT ADRENAL CORTICAL STEROIDS: STRUCTURE AND BIOLOGIC ACTIVITY
THORN, G. W., RENOLD, A. E., MORSE, W. I., GOLDFIEN, A., & REDDY, W. J. (1955) · Annals of Internal Medicine · doi:10.7326/0003-4819-43-5-979 · Cited by 59
Reduced Cortisol Metabolism During Critical Illness
Boonen, E., Vervenne, H. B. V. K., Meersseman, P., Andrew, R., Mortier, L., Declercq, P. E., Vanwijngaerden, Y.-M., Spriet, I., Woutlers, P. J., Perre, S. V., et al. (2014) · Survey of Anesthesiology · doi:10.1097/sa.0000000000000019 · Cited by 59
Timelines in the management of adrenal crisis – targets, limits and reality
Hahner, S., Hemmelmann, N., Quinkler, M., Beuschlein, F., Spinnler, C., & Allolio, B. (2015) · Clinical Endocrinology · doi:10.1111/cen.12609 · Cited by 56 · cited 1×
“Subcutaneous self-injection was the route of administration preferred by the patients, and the time delay in reaching peak cortisol concentrations compares favorably with the time from contacting emergency help until eventual glucocorticoid administration by health professionals (148).”
BackgroundSelf-citationFluorohydrocortisone and Chlorohydrocortisone, Highly Potent Derivatives of Compound F
Goldfien, A., Laidlaw, J. C., Haydar, N. A., Renold, A. E., & Thorn, G. W. (1955) · New England Journal of Medicine · doi:10.1056/nejm195503172521101 · Cited by 55
Oelkers, W. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390567 · Cited by 54 · cited 1×
“500 nmol/L (18 g/dL) (46, 53), the stimulated serum”
Ekman, B., Bachrach‐Lindström, M., Lindström, T., Wahlberg, J., Blomgren, J., & Arnqvist, H. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04352.x · Cited by 54 · cited 1×
“One doubleblind, randomized, crossover study evaluating two-dose vs four-dose hydrocortisone treatments (98) concluded that cortisol pharmacokinetics were more physiological on the four-dose regimen; surprisingly, participating patients preferred this regimen.”
BackgroundBinding of cortisol to human albumin and serum: The effect of protein concentration
Mueller, U. W., & Potter, J. M. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90158-1 · Cited by 54 · cited 1×
“cortisol to CBG (48) and to a lesser extent albumin (49).”
BackgroundLaureti, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3507 · Cited by 53
High Frequency of Coeliac Disease among Patients with Autoimmune Adrenocortical Failure
Myhre, A. G., Aarsetøy, H., Undlien, D. E., Hovdenak, N., Aksnes, L., & Husebye, E. S. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310002544 · Cited by 52 · cited 1×
“Because the prevalence of celiac disease in PAI is about 5% (156, 162, 163), screening for tissue Table 4.”
BackgroundSelf-citationBinder, G., Weber, S., Ehrismann, M., Zaiser, N., Meisner, C., Ranke, M. B., Maier, L., Wudy, S. A., Hartmann, M. F., Heinrich, U., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1982 · Cited by 52 · cited 1×
“adolescent adrenal insufficiency patients (118).”
Deutschbein, T., Unger, N., Mann, K., & Petersenn, S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0600 · Cited by 52 · cited 1×
“Unfortunately, most of the primary reports detailing this cutoff value are not based on subjects with PAI (23, 24, 61–64).”
BackgroundLaureti, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3163 · Cited by 52
Celiac disease in North Italian patients with autoimmune Addison’s disease
Betterle, C., Lazzarotto, F., Spadaccino, A. C., Basso, D., Plebani, M., Pedini, B., Chiarelli, S. M., & Albergoni, M. P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02089 · Cited by 51 · cited 1×
“Because the prevalence of celiac disease in PAI is about 5% (156, 162, 163), screening for tissue Table 4.”
BackgroundWhat is the best long‐term management strategy for patients with primary adrenal insufficiency?
Quinkler, M., & Hahner, S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04103.x · Cited by 50 · cited 1×
“Additional hydrocortisone (5 to 10 mg) has been discussed for prolonged intensive fitness training in patients with PAI (136).”
BackgroundGrapefruit juice and licorice increase cortisol availability in patients with Addison's disease
Methlie, P., Husebye, E. E. S., Hustad, S., Lien, E. A., & Løvås, K. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0518 · Cited by 50 · cited 1×
“Licorice and grapefruit juice potentiate the mineralocorticoid effect of hydrocortisone and should be avoided (109).”
BackgroundSelf-citationAssessing the HPA axis in patients with pituitary disease: a UK survey
Reynolds, R. M., Stewart, P. M., Seckl, J. R., & Padfield, P. L. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02421.x · Cited by 50 · cited 1×
“(im or iv), and the dose of corticotropin applied (26, 27).”
BackgroundSubcutaneous pulsatile glucocorticoid replacement therapy
Russell, G. M., Durant, C., Ataya, A., Papastathi, C., Bhake, R., Woltersdorf, W., & Lightman, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12470 · Cited by 49 · cited 1×
“Recently, the feasibility of pulsatile sc cortisol replacement was studied in healthy dexamethasone-suppressed individuals (175).”
BackgroundCho, H. Y., Kim, J. H., Kim, S. W., Shin, C. S., Park, K. S., Kim, S. W., Jang, H. C., & Kim, S.-Y. (2014) · Clinical Endocrinology · doi:10.1111/cen.12397 · Cited by 49
Screening for associated autoimmune disorders in Polish patients with Addison’s disease
Fichna, M., Fichna, P., Gryczyńska, M., Walkowiak, J., Żurawek, M., & Sowiński, J. (2010) · Endocrine · doi:10.1007/s12020-010-9312-x · Cited by 47 · cited 2×
“Because the prevalence of celiac disease in PAI is about 5% (156, 162, 163), screening for tissue Table 4.”
BackgroundCharacterization of the Cortisol Stress Response to Sedation and Anesthesia in Children
Hsu, A. A., von Elten, K., Chan, D., Flynn, T., Walker, K., Barnhill, J., Naun, C., Pedersen, A. M., Ponaman, M., Fredericks, G. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1499 · Cited by 45
A European Emergency Card for adrenal insufficiency can save lives
Quinkler, M., Dahlqvist, P., Husebye, E. S., & Kämpe, O. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.11.006 · Cited by 44 · cited 1×
“Recently, a new Swedish steroid card was introduced, with simple instructions in Swedish and English, and several European countries are now introducing the same card with the national language on one side and English on the other (155).”
BackgroundSelf-citationAcute adrenal crisis precipitated by thyroxine.
Fonseca, V, Brown, R., Hochhauser, D., Ginsburg, J., & Havard, C. W. (1986) · BMJ · doi:10.1136/bmj.292.6529.1185 · Cited by 44
Cortisol response to operative stress with anesthesia in healthy children
Taylor, L. K., Auchus, R. J., Baskin, L. S., & Miller, W. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2148 · Cited by 44 · cited 1×
“Studies provide evidence for an endogenous increase in cortisol during anesthesia, surgery, trauma, and critical illness, with great interindividual variation (137–141).”
BackgroundGrigorescu-Sido, A., Bettendorf, M., Schulze, E., Duncea, I., & Heinrich, U. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071876 · Cited by 42 · cited 1×
“In patients with CAH, glucocorticoid dosages exceeding 20 mg/m 2 /d in infants and 15 to 17 mg/m 2 /d in adolescents have been shown to result in loss of height and shorter adult stature (124, 125).”
BackgroundAdrenal Steroidogenesis after B Lymphocyte Depletion Therapy in New-Onset Addison's Disease
Pearce, S. H. S., Mitchell, A. L., Bennett, S., King, P., Chandran, S., Nag, S., Chen, S., Smith, B. R., Isaacs, J. D., & Vaidya, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1680 · Cited by 41 · cited 2×
“Treatment of newly diagnosed autoimmune PAI patients with rituximab (176) and established PAI patients with depot tetracosactide (177) has demonstrated that regenerationof cortisol production ispossible.”
BackgroundDetermining the utility of the 60 min cortisol measurement in the short synacthen test
Chitale, A., Musonda, P., McGregor, A. M., & Dhatariya, K. K. (2013) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04478.x · Cited by 39
(2005) · PubMed · Cited by 38
Vincent, R. P., Etogo-Asse, F. E., Dew, T., Bernal, W., Alaghband-Zadeh, J., & le Roux, C. W. (2009) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009030 · Cited by 37 · cited 1×
“Patients with diseases such as nephrotic syndrome (43) and liver disease (50) as well as those who are in the immediate postoperative period (51) or who require intensive care (52) may have lower CBG and albumin and hence, lower cortisol measurements.”
BackgroundReduced 11β-hydroxysteroid dehydrogenase type 1 activity in obese boys
Wiegand, S., Richardt, A., Remer, T., Wudy, S. A., Tomlinson, J. W., Hughes, B., Grüters, A., Stewart, P. M., Strasburger, C. J., & Quinkler, M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0193 · Cited by 37
Gan, E. H., MacArthur, K., Mitchell, A. L., Hughes, B. A., Perros, P., Ball, S. G., James, R. A., Quinton, R., Chen, S., Furmaniak, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2449 · Cited by 36 · cited 1×
“Treatment of newly diagnosed autoimmune PAI patients with rituximab (176) and established PAI patients with depot tetracosactide (177) has demon-stratedthatregenerationofcortisolproductionispossible.”
BackgroundSelf-citationFine tuning for quality of life: 21st century approach to treatment of Addison’s disease
Reisch, N., & Arlt, W. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.01.008 · Cited by 36 · cited 1×
“Moreover, long-term HRQoL in these patients appears to be inversely re-lated to the delay in establishing the diagnosis after disease onset, emphasizing the importance of recognizing the disease early (5, 6).”
BackgroundSelf-citation(2013) · PubMed · Cited by 35
Baker, P. R., Baschal, E. E., Fain, P. R., Triolo, T. M., Nanduri, P., Siebert, J. C., Armstrong, T. K., Babu, S. R., Rewers, M. J., Gottlieb, P. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0508 · Cited by 35 · cited 1×
“An elevated ACTH concentration in the presence of a cortisol in the normal range can be the first sign of early-stage PAI (68).”
BackgroundControl of mineralocorticoid substitution in Addison's disease by plasma renin measurement
Oelkers, W., & L'age, M. (1976) · Klinische Wochenschrift · doi:10.1007/bf01469025 · Cited by 34
Studies of the Control of Plasma Aldosterone Concentration in Normal Man
Williams, G. H., Tuck, M. L., Rose, L. I., Dluhy, R. G., & Underwood, R. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107082 · Cited by 33
Fiad, T. M., Conway, J. D., Cunningham, S. K., & McKenna, T. J. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00838.x · Cited by 33
National UK audit of the Short Synacthen ® Test
Chatha, K. K., Middle, J. G., & Kilpatrick, E. S. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009209 · Cited by 33
Progressive Adrenal Failure in Polyglandular Autoimmune Disease*
Saenger, P. H., LEVINE, S., IRVINE, J., Gottesdiener, K. M., Rauh, W., Sonino, N., Chow, D., & New, M. I. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-4-863 · Cited by 32
Cortisone replacement therapy in endocrine disorders – quality of self‐care
Harsch, I. A., Schuller, A., Hahn, E. G., & Hensen, J. (2010) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2009.01149.x · Cited by 31 · cited 1×
“%) were not sufficiently skilled in steroid management with physical stress (152).”
BackgroundAlonso, N., Granada, M. L., Lucas, A., Salinas, I., Reverter, J., Oriol, A., & Sanmartí, A. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03345290 · Cited by 30 · cited 1×
“Conversely, Alonso et al (99) found that HRQoL scores were similar and on some parameters worse on thrice-daily compared with twice-daily hydrocortisone.”
BackgroundBarbetta, L., Dall’Asta, C., Re, T., Libè, R., Costa, E., & Ambrosi, B. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347262 · Cited by 30 · cited 2×
“Lau-reti et al (96) and Barbetta et al (97) found that thrice-daily cortisone acetate lowered ACTH levels and gave 24-hour cortisol curves more similar to the endogenous cortisol rhythm compared with a two-dose regimen.”
MethodRoss, I. L., Bergthorsdottir, R., Levitt, N., Dave, J. A., Schatz, D., Marais, D., & Johannsson, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090768 · Cited by 29 · cited 1×
“Primary hypertension may also be present in PAI (111).”
BackgroundLaureti, S., Falorni, A., & Santeusanio, F. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345252 · Cited by 27 · cited 1×
“Lau-reti et al (96) and Barbetta et al (97) found that thrice-daily cortisone acetate lowered ACTH levels and gave 24-hour cortisol curves more similar to the endogenous cortisol rhythm compared with a two-dose regimen.”
MethodChristiansen, J. J., Bruun, J. M., Christiansen, J. S., Jørgensen, J. O., & Gravholt, C. H. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0289 · Cited by 26 · cited 1×
“In addition, some (but not all) studies have shown that DHEA replacement in adrenal insufficiency may improve HRQoL and mood, with reduced depression and anxiety scores (114–116).”
BackgroundCortisol response to general anaesthesia for medical imaging in children
Rains, P. C., Rampersad, N., De Lima, J., Murrell, D., Kinchington, D., Lee, J. W., Maguire, A. M., & Donaghue, K. C. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03591.x · Cited by 26
Dekkers, O. M., Timmermans, J. M., Smit, J. W. A., Romijn, J. A., & Pereira, A. M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0621 · Cited by 26 · cited 1×
“…thelow-doseandhigh-dosecorticotropinstimulationtests yield comparable results in the diagnostic workup of PAI and the low-dose test adds no further sensitivity or specificity over the high-dose test (47, 57), evidence has been presented that the low-dose corticotropin stimulation test Figure 1.”
ResultPatients' self administration of hydrocortisone.
Braatvedt, G. D., Newrick, P. G., & Corrall, R. J. (1990) · BMJ · doi:10.1136/bmj.301.6764.1312 · Cited by 25 · cited 3×
“In a survey study of 26 patients with Addison’s disease in the United Kingdom (153), only two patients could self-administer parenteral hydrocortisone, and 10 responders claimed never to have received injection teaching, although instruction was provided as unit policy.”
BackgroundFalorni, A., Brozzetti, A., Aglietti, M. C., Esposito, R., Minarelli, V., Morelli, S., Sbroma Tomaro, E., & Marzotti, S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04387.x · Cited by 25 · cited 1×
“Unlike premature ovarian insufficiency caused by nonautoimmune conditions, follicular function seems to be retained for up to several years after diagnosis in PAI patients (161).”
BackgroundBIOLOGICAL EFFECTS OF FLUORINATED DERIVATIVES OF HYDROCORTISONE AND PROGESTERONE IN MAN
Renold, A. E., Haydar, N. A., Reddy, W. J., Goldfien, A., Marc, J. R. S., & Laidlaw, J. C. (1955) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1955.tb42510.x · Cited by 23
Comparison of Absorption of Cortisone Acetate and Hydrocortisone Hemisuccinate*
Fariss, B. L., Hane, S., Shinsako, J., & Forsham, P. H. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-5-1137 · Cited by 23 · cited 1×
“The absorption curve of cortisone acetate is less steep and is delayed compared with that of hydrocortisone (89, 101), which might be favorable considering the short half-life of hydrocortisone.”
BackgroundScreening for X‐linked adrenoleukodystrophy among adult men with Addison's disease
Horn, M. A., Erichsen, M. M., Wolff, A. S. B., Månsson, J., Husebye, E. S., Tallaksen, C. M. E., & Skjeldal, O. H. (2013) · Clinical Endocrinology · doi:10.1111/cen.12159 · Cited by 22 · cited 1×
“Young males and males without autoantibodies should be screened for adrenoleukodystrophy by measuring very-long chain fatty acids (81, 82).”
BackgroundSelf-citationCortisol: ACTH ratio to test for primary hypoadrenalism: a pilot study
Lee, M. K. V., Vasikaran, S., Doery, J. C. G., Wijeratne, N., & Prentice, D. (2013) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2012-131723 · Cited by 22 · cited 3×
“Thus, we have recommended the 2 (cid:6) the upper limit of the reference interval, but in some cases of PAI it would be only above the quoted reference interval but not (cid:4) 2 (cid:6) the upper limit of the reference interval (19, 20).”
BackgroundFleming, L. K., Rapp, C. G., & Sloane, R. (2011) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2011.03.009 · Cited by 21 · cited 2×
“%) have been successfully used but should not be used with diarrhea; they have not been extensively studied and are not widely available (eg, not available in the United States).”
BackgroundManagement of hypertension and heart failure in patients with Addison's disease
Inder, W. J., Meyer, C., & Hunt, P. J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12592 · Cited by 20 · cited 1×
“If hypertension prevails after adjustment and the patient is euvolemic, angiotensin II receptor blockers or angiotensin-converting enzyme blockers may be used to counter the vasoconstrictive effects of elevated angiotensin II (112).”
BackgroundGrodstein, E. I., Hardy, M. A., & Goldstein, M. J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02929.x · Cited by 19 · cited 1×
“Gene therapy may potentially restore the defect in certain forms of monogenic PAI (178), and there is one report in the literature on successful adrenal transplantation (179).”
BackgroundKeilholz, U., & Guthrie, G. P. (1986) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198604000-00010 · Cited by 18 · cited 1×
“Phenytoin has been reported to increase fludrocortisone metabolism, leading to a need for higher replacement (110).”
BackgroundTNF MEDIATES A MURINE MODEL OF ADDISONʼS CRISIS
Koniaris, L. G., Wand, G., & Wright, T. M. (2001) · Shock · doi:10.1097/00024382-200115010-00005 · Cited by 16 · cited 1×
“Enhanced glucocorticoid secretion in critical illness is considered necessary to prevent defense mechanisms (eg, cytokine release) from overshooting with concomitant detrimental toxicity (142, 143).”
BackgroundPura, M., Kreze, A., Kentoš, P., & Vaňuga, P. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1202275 · Cited by 16
The 1 μg cosyntropin test in normal individuals: A reappraisal
Anantharaman, R., Menezes, G., Yusuf, R., Ganapathi, B., Ayyar, S., & Srinivasan, R. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.113763 · Cited by 12
Fadeev, V. V., Gitel', E. P., & Mel'nichenko, G. A. (2001) · Neuroscience and Behavioral Physiology · doi:10.1023/a:1010318130933 · Cited by 12 · cited 1×
“Dexamethasone should be avoided because Cushingoid side effects frequently appear (103).”
BackgroundEvaluation of ACTH immunoradiometric assays
Van Rijn, J. L. M. L., Van Landeghem, B. A. J., Haima, P., & Goldschmidt, H. M. J. (1996) · Clinical Biochemistry · doi:10.1016/0009-9120(95)02018-7 · Cited by 11 · cited 1×
“The challenge with setting a specific cut-point for ACTH levels suggesting PAI is highly influenced by analytical bias demonstrated in ACTH assays (69, 70).”
BackgroundCharmandari, E., & Chrousos, G. P. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00029-9 · Cited by 11
Rapid assessment of corticotropin reserve after pituitary surgery
Nb, W. (1988) · JAMA · doi:10.1001/jama.259.5.708 · Cited by 9
Addison's disease: a diagnostic challenge
Jones, D. A., Miras, A. D., & Tringham, J. R. (2008) · British Journal of Hospital Medicine · doi:10.12968/hmed.2008.69.sup12.31945 · Cited by 6 · cited 1×
“Therefore, it is essential to keep the threshold for diagnostic evaluation low (2, 37).”
BackgroundSCHTEINGART, D. E. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79160-1 · Cited by 6
SCHTEINGART, D. E. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70189-6 · Cited by 6
Rapid Adrenocorticotropic Hormone Test in Practice. Retrospective Review
May, M. E., & Carey, R. M. (1986) · The Journal of Urology · doi:10.1016/s0022-5347(17)46126-x · Cited by 6
Charmandari, E., Kino, T., & Chrousos, G. P. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_4 · Cited by 6
Progressive adrenal failure in polyglandular autoimmune disease
Saenger, P. H., Levine, L. S., Irvine, W. J., et al. (1981) · Pediatric Research · doi:10.1203/00006450-198112000-00146 · Cited by 5 · cited 1×
“mineralocorticoid deficiency may predominate (71) and”
(2001) · PubMed · Cited by 5
(1978) · PubMed · Cited by 3
Self-citation
Research works printed but not linked: 3
- [29]29. Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insuffi- ciency. Ann Intern Med. 2003;139:194 -204.
- [110]110. Keilholz U, Guthrie GP Jr. Adverse effect of phenytoin on miner- alocorticoid replacement with fludrocortisone in adrenal insuffi- ciency. Am J Med Sci. 1986;291:280 -283.
- [177]177. Gan EH, MacArthur K, Mitchell AL, et al. Residual adrenal func- tion in autoimmune Addison's disease: improvement after tetra- cosactide (ACTH1-24) treatment. J Clin Endocrinol Metab. 2014; 99:111-118.
Cited by
Brahmer, J. R., Lacchetti, C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., Ernstoff, M. S., Gardner, J. M., Ginex, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6385 · Cited by 3,713
“Fludrocortisone is needed in addition to hydrocortisone in most cases of primary adrenal insufficiency, which involves the loss of mineralocorticoid as well as glucocorticoid, leading to more-profound blood pressure and electrolyte abnormalities.(63) Monitoring is also affected by localization, as pituitary hormones a…”
BackgroundSchneider, B. J., Naidoo, J., Santomasso, B. D., Lacchetti, C., Adkins, S., Anadkat, M., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.01440 · Cited by 2,372
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Self-citationWeiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citation
Metadata
- Authors
- Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., & Torpy, D. J.
- Affiliations
- King's College London (GB)
- Mayo Clinic (US)
- National Institutes of Health (US)
- Royal Adelaide Hospital (AU)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-02
- Volume
- 101
- Issue
- 2
- Pages
- 364-389
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4880116
- OpenAlex
- W2234917292
- Cited by
- 1,769
- References
- 222
- Citations by year
- 2026: 187 · 2025: 198 · 2024: 180 · 2023: 191 · 2022: 180 · 2021: 206 · 2020: 165 · 2019: 149 · 2018: 148 · 2017: 102 · 2016: 54
- FWCI
- 151.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by-nc-nd)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- European Society of Endocrinology
- Novo Nordisk Fonden (NNF14OC0011005)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK062027)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- Addison's disease, diagnosis, hydrocortisone replacement, fludrocortisone, corticosteroid dose, stress dosing, 21-hydroxylase autoantibodies, autoimmune thyroid disease, pregnancy, glucocorticoid therapy, autoimmune adrenal insufficiency
- MeSH terms
- Adrenal Insufficiency, Female, Humans, Pregnancy, Societies, Medical, Evidence-Based Medicine, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.